|
KraneShares MSCI All China Health Care Index ETF
|
||||||||||||||||||
- Description
- Performance
- Comps
Fundamentals
Valuation
Rating
| The KraneShares MSCI All China Health Care Index ETF tracks an index of large- and midcap Chinese stocks in the health care sector, weighted by market capitalization. |
| Category | Emerging Market Equities |
| Fund Sponsor | KraneShares |
| Website | kraneshares.com |
| Inception date | Jan 31, 2018 |
| Assets (mns) | $79 |
| Currency | USD |
| Expense ratio | 65 bp |
| Distributions | Semi-annual |
| Regulation | Open-Ended Fund |
| Custodian | |
| Weighting | Market Cap |
| Index replication | |
| Uses derivatives | No |
| Options available | Yes |
| No. of constituents | 50 |
| Wgt avg mkt cap (mns) | $17,065 |
| Large cap (>$10bn) | 52.3% |
| Mid cap ($2-10bn) | 47.7% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts | 19.1% |
| Emerging mkts | 80.9% |
| BEIGENE, LTD. | 9.2 % |
| INNOVENT BIOLOGICS, INC. | 8.6 % |
| WUXI BIOLOGICS (CAYMAN) INC. | 7.7 % |
| WUXI APPTEC CO., LTD. CLASS A | 6.3 % |
| JIANGSU HENGRUI MEDICINE CO., LTD. | 4.6 % |
| SHENZHEN MINDRAY BIO-MEDICAL ELECT | 4.4 % |
| AKESO, INC. | 3.8 % |
| CHINA PHARMACEUTICAL GROUP | 3.8 % |
| WUXI APPTEC CO., LTD. CLASS H | 3.7 % |
| SINO BIOPHARMACEUTICAL | 3.5 % | Total | 55.6 % |
|---|
| CHINA | 83.0 % | |
| HONG KONG | 7.3 % | |
| UNITED STATES | 1.2 % |
HISTORICAL PERFORMANCE 

| Custom date range | Compare to | ||
| thru |
| Year-to-date | 1 year | 5 years | 10 years | Since Incep. |
| 1.4% | -8.3% | -12.0% | -- | -1.9% |
| versus... | Beta | R-squared |
| S&P500 | 0.68 | 9% |
| MSCI EAFE | 0.64 | 12% |
| MSCI Emg. Mkts. | 0.43 | 14% |
| Recent close | $17.46 |
| 30d moving avg. | $16.61 |
| Annualized volatility | 28.5% |
| Short interest (ETF) | 13.5% |
| Relative strength (RSI) | 55 |
| Avg. volume (thou.) | 87 |
| Turnover | 1.9% |
| Bid/Ask (% of price) | 1.11% |
| ADV underlying (mns) | $2,220 |
FINDING ALTERNATIVE FUNDS
Below is a list of 125 potential alternatives to the KraneShares MSCI All China Health Care Index ETF ETF based on the alternatives' overlap in portfolio holdings with KURE. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.
| Benchmark ticker: | KURE | Expense: | 65 bp | ALTAR Score™: | 2.7% |
| Ticker | Fund Name |
Overlap1 vs KURE (%) |
Expense ratio (bp) |
Savings vs KURE (bp) |
ALTAR Score™ (%) |
ALTAR vs KURE (%) |
| OZEM | Roundhill GLP-1 & Weight Loss ETF | 9.2 | 59 | 6 | 5.4 | +2.7 |
| FCA | First Trust China AlphaDEX Fund | 7.6 | 80 | -15 | 8.4 | +5.7 |
| CGRO | CoreValues Alpha Greater China Growth ETF | 6.9 | 75 | -10 | 5.0 | +2.3 |
| CXSE | WisdomTree China ex-State-Owned Enterprises Fund | 5.7 | 32 | 33 | 14.1 | +11.4 |
| MCH | Matthews China Active ETF | 4.6 | 79 | -14 | 14.8 | +12.1 |
| JCHI | JPMorgan Active China ETF | 4.2 | 65 | 0 | 15.1 | +12.4 |
| FLCH | Franklin FTSE China ETF | 3.8 | 19 | 46 | 17.8 | +15.1 |
| KBA | KraneShares Bosera MSCI China A 50 Connect Index ETF | 3.6 | 55 | 10 | 6.4 | +3.7 |
| MCHI | iShares MSCI China ETF | 3.6 | 59 | 6 | 20.0 | +17.3 |
| ASHR | Xtrackers Harvest CSI 300 China A-Shares ETF | 3.5 | 65 | 0 | 6.3 | +3.6 |
| GXC | SPDR S & P China ETF | 2.8 | 59 | 6 | 18.7 | +16.0 |
| MDEV | First Trust Indxx Medical Devices ETF | 2.5 | 70 | -5 | 4.6 | +1.9 |
| GNOM | Global X Genomics & Biotechnology ETF | 2.3 | 50 | 15 | -2.3 | -4.9 |
| BKF | iShares MSCI BIC ETF | 2.1 | 69 | -4 | 14.4 | +11.7 |
| UEVM | VictoryShares Emerging Markets Value Momentum ETF | 1.9 | 45 | 20 | 9.4 | +6.8 |
| KSTR | KraneShares SSE STAR Market 50 Index ETF | 1.9 | 89 | -24 | 0.7 | -2.0 |
| AGNG | Global X Aging Population ETF | 1.7 | 50 | 15 | 4.2 | +1.5 |
| SAGP | Strategas Global Policy Opportunities ETF | 1.6 | 65 | 0 | 4.6 | +1.9 |
| MINV | Matthews Asia Innovators Active ETF | 1.6 | 79 | -14 | 5.5 | +2.9 |
| LDEM | iShares ESG MSCI EM Leaders ETF | 1.6 | 17 | 48 | 12.5 | +9.9 |
| CNYA | iShares MSCI China A ETF | 1.5 | 60 | 5 | 6.5 | +3.9 |
| ROAM | Hartford Multifactor Emerging Markets ETF | 1.5 | 44 | 21 | 7.5 | +4.9 |
| RAYE | Rayliant Quantamental Emerging Market ex-China Equity ETF | 1.5 | 88 | -23 | 8.4 | +5.7 |
| ECOW | Pacer Emerging Markets Cash Cows 100 ETF | 1.4 | 70 | -5 | 9.2 | +6.6 |
| EEMO | Invesco S&P Emerging Markets Momentum ETF | 1.4 | 29 | 36 | 6.8 | +4.1 |
| EMXF | iShares ESG Advanced MSCI EM ETF | 1.4 | 16 | 49 | 6.6 | +3.9 |
| AVSE | Avantis Responsible Emerging Markets Equity ETF | 1.2 | 33 | 32 | 6.6 | +3.9 |
| CANC | Tema Oncology ETF | 1.2 | 75 | -10 | -2.2 | -4.8 |
| PBE | Invesco Biotechnology & Genome ETF | 1.2 | 58 | 7 | 1.7 | -1.0 |
| FMED | Fidelity Disruptive Medicine ETF | 1.2 | 50 | 15 | -1.1 | -3.8 |
| MEDI | Harbor Health Care ETF | 1.2 | 80 | -15 | -1.4 | -4.0 |
| EYLD | Cambria Emerging Shareholder Yield ETF | 1.2 | 66 | -1 | 9.0 | +6.3 |
| EEMA | iShares MSCI Emerging Markets Asia ETF | 1.2 | 49 | 16 | 7.5 | +4.8 |
| BBP | Virtus LifeSci Biotech Products ETF | 1.1 | 79 | -14 | -3.6 | -6.3 |
| ESGE | iShares ESG Aware MSCI EM ETF | 1.1 | 25 | 40 | 8.2 | +5.5 |
| GEM | Goldman Sachs ActiveBeta Emerging Markets Equity ETF | 1.1 | 45 | 20 | 8.0 | +5.3 |
| BBAX | JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF | 1.1 | 19 | 46 | 5.1 | +2.4 |
| NUEM | Nuveen ESG Emerging Markets Equity ETF | 1.1 | 36 | 29 | 5.9 | +3.3 |
| FEM | First Trust Emerging Markets AlphaDEX Fund | 1.1 | 80 | -15 | 8.8 | +6.2 |
| EMCR | Xtrackers Emerging Markets Carbon Reduction and Climate Impr | 1.1 | 15 | 50 | 8.8 | +6.1 |
| XSOE | WisdomTree Emerging Markets ex-State-Owned Enterprises Fund | 1.0 | 32 | 33 | 7.5 | +4.8 |
| BMED | Future Health ETF | 1.0 | 85 | -20 | 1.1 | -1.6 |
| SCHE | Schwab Emerging Markets Equity ETF | 1.0 | 11 | 54 | 9.3 | +6.6 |
| GMF | SPDR S&P Emerging Asia Pacific ETF | 1.0 | 49 | 16 | 8.5 | +5.8 |
| FLAX | Franklin FTSE Asia Ex Japan ETF | 0.9 | 19 | 46 | 7.1 | +4.4 |
| VWO | Vanguard FTSE Emerging Markets ETF | 0.9 | 7 | 58 | 9.0 | +6.4 |
| DFSE | Dimensional Emerging Markets Sustainability Core 1 ETF | 0.9 | 41 | 24 | 6.9 | +4.2 |
| ECON | Columbia Emerging Markets Consumer ETF | 0.9 | 49 | 16 | 6.6 | +3.9 |
| AAXJ | iShares MSCI All Country Asia ex Japan ETF | 0.8 | 70 | -5 | 6.9 | +4.2 |
| AVEM | Avantis Emerging Markets Equity ETF | 0.8 | 33 | 32 | 7.0 | +4.4 |
| EEMX | SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF | 0.8 | 30 | 35 | 7.9 | +5.2 |
| DBEM | Xtrackers MSCI Emerging Markets Hedged Equity ETF | 0.8 | 66 | -1 | 7.3 | +4.6 |
| JHEM | John Hancock Multifactor Emerging Markets ETF | 0.8 | 49 | 16 | 7.5 | +4.8 |
| HEEM | iShares Currency Hedged MSCI Emerging Markets ETF | 0.8 | 69 | -4 | 7.6 | +4.9 |
| EMMF | WisdomTree Emerging Markets Multifactor Fund | 0.8 | 48 | 17 | 8.6 | +5.9 |
| EEM | iShares MSCI Emerging Markets ETF | 0.7 | 69 | -4 | 7.8 | +5.1 |
| FXI | iShares China Large-Cap ETF | 0.7 | 74 | -9 | 20.4 | +17.7 |
| GSEE | Goldman Sachs MarketBeta Emerging Markets Equity ETF | 0.7 | 36 | 29 | 7.5 | +4.9 |
| SPEM | SPDR Portfolio Emerging Markets ETF | 0.7 | 7 | 58 | 9.4 | +6.7 |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | 0.7 | 38 | 27 | 7.0 | +4.4 |
| BKEM | BNY Mellon Emerging Markets Equity ETF | 0.7 | 11 | 54 | 24.0 | +21.4 |
| EMGF | iShares Emerging Markets Equity Factor ETF | 0.7 | 25 | 40 | 8.9 | +6.2 |
| IEMG | iShares Core MSCI Emerging Markets ETF | 0.6 | 9 | 56 | 8.2 | +5.5 |
| ASHS | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF | 0.6 | 65 | 0 | 4.7 | +2.1 |
| DFAE | Dimensional Emerging Core Equity Market ETF | 0.6 | 35 | 30 | 7.0 | +4.3 |
| BBEM | JPMorgan BetaBuilders Emerging Markets Equity ETF | 0.6 | 15 | 50 | 8.0 | +5.3 |
| CNXT | VanEck ChiNext ETF | 0.5 | 65 | 0 | 3.0 | +0.3 |
| QEMM | SPDR MSCI Emerging Markets StrategicFactors ETF | 0.5 | 30 | 35 | 7.5 | +4.8 |
| EVLU | iShares MSCI Emerging Markets Value Factor ETF | 0.5 | 35 | 30 | 9.9 | +7.3 |
| AVES | Avantis Emerging Markets Value ETF | 0.5 | 36 | 29 | 9.0 | +6.3 |
| JPEM | JPMorgan Diversified Return Emerging Markets Equity ETF | 0.5 | 44 | 21 | 9.3 | +6.6 |
| SDG | iShares MSCI Global Sustainable Development Goals ETF | 0.5 | 49 | 16 | 4.5 | +1.8 |
| FRGN | Horizon International Equity ETF | 0.5 | 75 | -10 | 7.7 | +5.0 |
| EELV | Invesco S&P Emerging Markets Low Volatility ETF | 0.4 | 29 | 36 | 8.7 | +6.0 |
| PXH | Invesco FTSE RAFI Emerging Markets ETF | 0.3 | 49 | 16 | 13.1 | +10.4 |
| VSGX | Vanguard ESG International Stock ETF | 0.3 | 10 | 55 | 6.4 | +3.8 |
| FNDE | Schwab Fundamental Emerging Markets Large Co. Index ETF | 0.3 | 39 | 26 | 13.3 | +10.6 |
| TLTE | FlexShares Morningstar Emerging Markets Factor Tilt Index | 0.3 | 59 | 6 | 8.5 | +5.8 |
| AVEE | Avantis Emerging Markets Small Cap Equity ETF | 0.3 | 42 | 23 | 7.8 | +5.2 |
| GXUS | Goldman Sachs MarketBeta Total International Equity ETF | 0.3 | 18 | 47 | 6.2 | +3.5 |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | 0.3 | 30 | 35 | 6.3 | +3.6 |
| VEU | Vanguard FTSE All-World ex-US Index Fund | 0.3 | 4 | 61 | 6.5 | +3.9 |
| IBB | iShares Biotechnology ETF | 0.3 | 45 | 20 | -0.5 | -3.2 |
| DBAW | Xtrackers MSCI All World ex US Hedged Equity ETF | 0.3 | 41 | 24 | 5.8 | +3.1 |
| GPT | Intelligent Alpha Atlas ETF | 0.3 | 69 | -4 | 6.1 | +3.4 |
| VXUS | Vanguard Total International Stock ETF | 0.2 | 5 | 60 | 6.5 | +3.8 |
| ACWX | iShares MSCI ACWI ex U.S. ETF | 0.2 | 34 | 31 | 6.2 | +3.5 |
| MFEM | PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF | 0.2 | 50 | 15 | 8.2 | +5.5 |
| DEHP | Dimensional Emerging Markets High Profitability ETF | 0.2 | 41 | 24 | 4.8 | +2.2 |
| CWI | SPDR MSCI ACWI ex-US ETF | 0.2 | 30 | 35 | 6.3 | +3.6 |
| IXUS | iShares Core MSCI Total International Stock ETF | 0.2 | 7 | 58 | 6.4 | +3.8 |
| JEMA | JPMorgan ActiveBuilders Emerging Markets Equity ETF | 0.2 | 33 | 32 | 6.7 | +4.0 |
| DFEV | Dimensional Emerging Markets Value ETF | 0.2 | 43 | 22 | 9.4 | +6.7 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.2 | 19 | 46 | 0.3 | -2.4 |
| UIVM | VictoryShares International Value Momentum ETF | 0.2 | 35 | 30 | 7.7 | +5.1 |
| TPIF | Timothy Plan International ETF | 0.2 | 62 | 3 | 5.4 | +2.7 |
| RNEM | First Trust Emerging Markets Equity Select ETF | 0.2 | 75 | -10 | 7.7 | +5.1 |
| NZAC | SPDR MSCI ACWI Climate Paris Aligned ETF | 0.1 | 12 | 53 | 4.3 | +1.7 |
| DNL | WisdomTree Global ex-US Quality Dividend Growth Fund | 0.1 | 42 | 23 | 4.0 | +1.3 |
| XT | iShares Exponential Technologies ETF | 0.1 | 46 | 19 | 3.9 | +1.2 |
| VT | Vanguard Total World Stock ETF | 0.1 | 6 | 59 | 4.9 | +2.2 |
| IQSI | IQ Candriam International Equity ETF | 0.1 | 15 | 50 | 5.4 | +2.8 |
| FNDC | Schwab Fundamental International Small Co. Index ETF | 0.1 | 39 | 26 | 6.6 | +3.9 |
| ACWI | iShares MSCI ACWI ETF | 0.1 | 32 | 33 | 4.5 | +1.9 |
| EEMV | iShares MSCI Emerging Markets Min Vol Factor ETF | 0.1 | 25 | 40 | 6.0 | +3.3 |
| VYMI | Vanguard International High Dividend Yield ETF | 0.1 | 17 | 48 | 7.7 | +5.0 |
| ACWV | iShares MSCI Global Min Vol Factor ETF | 0.1 | 20 | 45 | 5.6 | +2.9 |
| GLOF | iShares Global Equity Factor ETF | 0.1 | 20 | 45 | 5.4 | +2.7 |
| AQLT | iShares MSCI Global Quality Factor ETF | 0.1 | 18 | 47 | 0.0 | -2.7 |
| CIL | VictoryShares International Volatility Wtd ETF | 0.1 | 45 | 20 | 5.9 | +3.2 |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.1 | 20 | 45 | 0.8 | -1.9 |
| GSID | Goldman Sachs MarketBeta International Equity ETF | 0.1 | 20 | 45 | 5.6 | +3.0 |
| BKIE | BNY Mellon International Equity ETF | 0.1 | 4 | 61 | 17.4 | +14.7 |
| JSTC | Adasina Social Justice All Cap Global ETF | 0.0 | 89 | -24 | 4.2 | +1.5 |
| SPGM | SPDR Portfolio MSCI Global Stock Market ETF | 0.0 | 9 | 56 | 4.7 | +2.1 |
| CRBN | iShares MSCI ACWI Low Carbon Target ETF | 0.0 | 20 | 45 | 4.6 | +1.9 |
| FBCG | Fidelity Blue Chip Growth ETF | 0.0 | 59 | 6 | 2.2 | -0.5 |
| DIVI | Franklin International Core Dividend Tilt Index ETF | 0.0 | 9 | 56 | 6.4 | +3.7 |
| TLTD | FlexShares Morningstar Developed Markets ex-US Factor Tilt | 0.0 | 39 | 26 | 6.8 | +4.1 |
| MFDX | PIMCO RAFI Dynamic Multi-Factor International Equity ETF | 0.0 | 39 | 26 | 6.1 | +3.4 |
| GLOV | Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF | 0.0 | 25 | 40 | 5.4 | +2.7 |
| VIGI | Vanguard International Dividend Appreciation ETF | 0.0 | 10 | 55 | 5.8 | +3.2 |
| PXF | Invesco FTSE RAFI Developed Markets ex-U.S. ETF | 0.0 | 45 | 20 | 6.6 | +3.9 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.0 | 21 | 44 | 2.9 | +0.2 |
| APIE | ActivePassive International Equity ETF | 0.0 | 45 | 20 | 6.2 | +3.5 |
1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.
Content on this tab for subscribers only**
RESULTS & ESTIMATES
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | |
|---|---|---|---|---|---|---|---|
| Sales per share | ** | ** | ** | ** | ** | ** | ** |
| Earnings per share | ** | ** | ** | ** | ** | ** | ** |
Dividends per share ![]() |
** | ** | ** | ** | ** | ** | ** |
| Book value per share | ** | ** | ** | ** | ** | ** | ** |
| Sales per share growth | **% | **% | **% | **% | **% | **% | |
| EPS growth | **% | **% | **% | **% | **% | **% |
| Sales per share growth | **% | **% | **% | **% | **% | **% | |
| EPS growth | **% | **% | **% | **% | **% | **% |
OTHER FUNDAMENTAL METRICS
| Long term EPS growth est. | **% | Debt-to-equity | **x | |
| Asset turnover | **% | Assets-to-equity | **x |
| *Six months ago = 100 |
Content on this tab for subscribers only
VALUATION METRICS
| 2024 | 2025E | 2026E | |
|---|---|---|---|
| Price-to-sales | ** | ** | ** |
| Price-to-earnings | ** | ** | ** |
| Price-to-cash flow | ** | ** | ** |
| Price-to-growth | ** | ** | ** |
| Price-to-book value | ** | ** | ** |
| Yield | ** | ** | ** |
Historical valuation trends
| Forward multiple: |
KraneShares MSCI All China Health Care Index ETF | |||
| Relative to: |
S&P500 | MSCI EAFE | MSCI Emg. Mkts. | Other ETF: |
AVOID |
| Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
|
ALTAR Score™
|
MODERN PORTFOLIO THEORY
![]() |
||||||||||||||||||||
CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
|
||||||||||||||
